Abstract
Behavioral pharmacology or psychopharmacology is the study of the effects of drugs on behavior, whereas neuropharmacology is concerned with the effects of drugs on nervous tissue. Thus, neuropsychopharmacology encompasses the whole spectrum, being concerned with the study of the effects of drugs on both nervous tissue in general and on behavior in particular.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ananth, J. (1982) Benzodiazepines: Selective use to avoid addiction.Postgraduate Med 72, 271–276.
Barnett, A., Goldstein, J., Fiedler, E., and Taber, R. (1975) Etonitazene- induced rigidity and its antagonism by centrally acting muscle relaxants. Eur. J. Pharmacol. 30, 23–28.
Beer, B. and Migler, B. (1975) Effects of Diazepam on Galvanic Skin Response and Conflict in Monkeys and Humans, in Predictability in Psychopharmacology: Preclinical and Clinical Correlations ( Sudilovsky, A., Gershon, S., and Beer, B., eds.) Raven, New York.
Bernard, P, Bergen, K„ Sobiski, R., and Robson, R. (1981) CGS 8216 (2-phenylpyrazolo) [4,3-c] quinolin-3(5Hl)-one), an orally effective benzodiazepine antagonist. Pharmacologist 23, 150.
Bernard, P. S., Bennett, D. A., Pastor, G., Yokoyama, N., and Liebman, J. M. (1985) CGS 9896: Agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents. J. Pharmacol. Exp. Ther. 235, 98–105.
Boast, C. A., Gerhardt, S. C., Gajary, Z. L., and Brown, W. N. (1985) Lack of withdrawal effects in mice after chronic administration of the non-sedating anxiolytic CGS 9886. Soc. Neurosci. Abst. 11, 424.
Braestrup, C., Nielsen, M., and Olsen, C. E. (1980) Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc. Natl. Acad. Sci. USA 77, 2288–2292.
Canon, J. and House, V. P. (1978) Squirrel monkey active conflict test Physiol. Psychol. 6, 215–222.
Collins, R. L. (1972) Audiogenic Seizures, in Experimental Models of Epilepsy—A Manual for the Laboratory Worker ( Purpura, D. P., Penry, J. K., Tower, D., VVoodbury, D. M., and Walter, R., eds.) Raven, New York.
Cook, L. and Davidson, A. B. (1973) Effects of Behaviorallv Active Drugs in a Conflict-Punishment Procedure in Rats, in The Benzodiazepines ( Garattini, S., Mussini, E., and Randall, L. O., eds.) Raven, New York.
Cook, L. and Sepinwall, J. (1975) Behavioral Analysis of the Effects and Mechanisms of Action of Benzodiazepines, in Mechanism of Action of Benzodiazepines ( Costa, E. and Greengard, P., eds.) Raven, New York.
Costa, E. and Guidotti, A. (1979) Molecular mechanisms in the receptor actions of benzodiazepines. Ann. Rev. Pharmacol. Toxicol. 19, 531–545.
Costa, E., Guidotti, A., and Mao, C. C. (1975a) Evidence for Involvement of GABA in the Action of Benzodiazepines: Studies on Rat Cerebellum, in Mechanism of Action of Benzodiazepines ( Costa, E. and Greengard, P., eds.) Raven, New York.
Costa, E., Guidotti, A., Mau, C, and Suria, A. (1975b) New concepts in the mechanism of benzodiazepines. Life Sci. 17, 167–186.
Covi, L., Lippman, R. S., and Pattison, J. H. (1973) Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatr. Scand. 49, 51–64.
Curtis, D. R., Duggan, A. W., Felix, D., and Johnston, G. A. R. (1970) GABA, bicuculline and central inhibition. Nature 226, 1222–1224.
Dompert, W. U., Glaser, T., and Traber, T. (1985) 3H-TVX Q 7821: Identification of 5-HT, binding sites as target for a novel putative anxiolytic. Naunyn Schmiedebergs Arch. Pharmacol. 38, 467–470.
Eison, M. S., Taylor, D. P., Riblet, L. A., New, J. S., Temple, D. L., Jr., and Yevich, J. P. (1982) MJ 13805-1: A potential nonbenzodiazepine anxiolytic. Soc. Neurosci. Abst. 8, 470.
Ellis, K. O. and Carpenter, J. F. (1974) A comparative study of dantrolene sodium and other skeletal muscle relaxants with the Straub tail mouse. Neuropharmacology 13, 211–214.
File, S. E. (1982) Chlordiazepoxide-induced ataxia, muscle relaxation and sedation in the rat: Effects of muscimol, picrotoxin and naloxone. Pharmacol. Biochem. Behav. 17, 1165–1170.
File, S. E., Lister, R. G., and Nutt, D. J. (1982) The anxiogenic action of benzodiazepine antagonists. Neuropharmacology 21, 1033–1037.
Food and Drug Administration (1980) FDA Consumer 13, 21–23.
Gehlbach, G. and VanderMaelen, C. P. (1985) The non-benzodiazepine antidepressant-anxiolytic candidate, gepirone, inhibits serotonergic dorsal raphe neurons in the rat brain slice. Soc. Neurosci. Abst. 11, 186.
Geller, I. and Seifter, J. (1960) The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination. Psychophartnacologia (Berl.) 3, 374–385.
Goldberg, H. L. and Finnerty, R. J. (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiat. 136. 1184–1187.
Goldberg, M. E„ Salama, A. I., Patel, J. B., and Malick, J. B. (1983) Novel nonbenzodiazepine anxiolytics. Neuropharmacology 22, 1499–1504.
Goldstein, J. M., Knobloch, L. C., and Malick, J. B. (1983) GABAmimetic properties of anxiolytic drugs. Life Sci. 32, 613–616.
Griffiths, R. R., Lamb, R. J., Ator, N. A., Roache, J. D., and Brady, J. V. (1985) Relative abuse liability of triazolam: Experimental assessment in animals and humans. Neurosci. Biobehav. Rev. 9, 133–151.
Hanson, H. M., Witoslawaski, J. J., and Campbell, E. H. (1967) Drug effects in squirrel monkeys trained on a multiple schedule with a punishment contingency. J. Exp. Anal. Behav. 10, 565–569.
Hunkeler, W., Mohler, H., Pieri, L., Pole, P., Bonetti, E. P., Cumin, R., Schaffner, R., and Haefely, W. (1981) Selective antagonists of benzodiazepines. Nature 290, 514–516.
Irwin, S. (1967) Anti-neurotics: Practical Pharmacology of Sedative- Hypnotic and Minor Tranquilizers, in Psychopharmacology: A Review of Progress 1957-1967 (Efron, D. H., ed.) US Public Health Service publication no. 1836, Bethesda, Maryland.
King, E. E. and Unna, K. R. (1954) The action of mephenesin and other interneuron depressants on the brain stem. J. Pharmacol. Exp. Ther., 111 293–301.
Kinnard, W. T. and Carr, C. T. (1957) A preliminary procedure for the evaluation of central nervous svstem depressants. J. Pharmacol. Exp. Ther. 121, 354–361.
Knowles, W. and Ukena, T. (1973) The effects of chlorpromazine, pentobarbital, chlordiazepoxide and d-amphetamines on rates of licking in the rat. J. Pharmacol. Exp. Ther. 184, 385–397.
Lader, M. and Petursson, H. (1983) Abuse Liability of Anxiolytics, in Anxiolytics: Neurochemical. Behavioral and Clinical Perspectives ( Malick, J. B., Enna, S. J., and Yamamura, H. I., eds.) Raven, New York.
Lippa, A. S., Coupet, J., Greenblatt, E. N., Klepner, C. A., and Beer. B. (1979a) A synthetic non-benzodiazepine ligand for benzodiazepine receptors: A probe for investigating neuronal substrates of anxiety. Pharamcol. Biochem. Behav. 11, 99–106.
Lippa, A. S., Nash, P. A., and Greenblatt, E. N. (1979b) Preclinical Neuro- psychopharmacological Testing Procedures for Anxiolytic Drugs, in Industrial Phartttacology, Vol. 3: Anxiolytics ( Fielding, S. and Lal, H, eds.) Futura, Mount Kisco, New York.
Litchfield, J. F., Jr. and Wilcoxon, F. (1949) A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96. 99–115.
Malick, J. B. (1976) Pharmacological antagonism of mouse-killing behavior in the olfactory bulb lesion-induced killer rat. Aggressive Behav. 2, 123–130.
Malick, J. B. (1985) Audiogenic seizure susceptible (AGS) mice: Utility as a screen for anti-epileptic agents. Fed. Proc. 44, 1106.
Malick, J. B. and Enna, S. J. (1979) Comparative effects of benzodiazepines and non-benzodiazepine anxiolytics on biochemical and behavioral tests predictive of anxiolytic activity. Commun. Psychopharmacol. 3, 245–252.
Malick, J. B. and Kubena, R. K. (1979) Benzodiazepines: Treatment of Acute Alcohol Withdrawal and Long-Term Management of Alcoholics, in Industrial Pharmacology vol. 3 Anxiolytics ( Fielding, S. and Lal, H., eds.) Futura, Mount Kisco, New York.
Malick, J. B., Patel, J. B., Salama, A. I., Meiners, B. A., Giles, R. E„ and Goldberg, M. E. (1984) Tracazolate: A novel nonsedative anxiolytic. Drug Develop. Res. 4, 61–73.
Malick, J. B„ Patton, S. P., and Patel, J. B. (1986) Dissimilar characteristics of the benzodiazepine antagonist profiles of CGS 9895 and CGS 9896. Pharmacologist 28. 112.
Niemegeers, C. J. E. and Lewi, P. J. (1979) The Anticonvulsant Properties of Anxiolytic Agents, in Industrial Pharmacology vol. 3 Anxiolytics ( Fielding, S. and Lal, H., eds.) Futura Mount Kisco, New York
Niki, H. (1965) Chlordiazepoxide and food intake in the rat. Jap. Psychol. Res. 7, 80–85.
Novak, G. D. (1982) Studies on the efficacy and depressant potential of muscle relaxants in mice. Drug Develop. Res. 2. 383–386.
Novak, G. D. and Zwolshen, J. M. (1983) Predictive value of muscle relaxant models in rats and cats. J. Pharmacol. Meth. 10, 175–183.
Overweg, J. and Binnie, C. D. (1983) Benzodiazepines in Neurological Disorders, in The Benzodiazepines: From Molecular Biology to Clinical Practice ( Costa, E., ed.) Raven, New York.
Palva, E. S. and Linnoilia, M. (1978) Effect of active metabolites of chlordiazepoxide and diazepam, alone and in combination with alcohol, on psychomotor skills related to driving. Eur.J. Pharmacol. 13, 345–350.
Patel. J. B. and Malick, J. B. (1980a) Lack of tolerance to the potentiation of ethanol-induced depression by benzodiazepines following sub-acute administration in mice. Fed. Proc. 39, 318.
Patel, J. B. and Malick, J. B. (1980b) Effects of isoproterenol and chlor-diazepoxide on drinking and conflict behavior in rats. Pharmacol. Biochem. Behav. 12, 819–821.
Patel, J. B. and Malick, J. B. (1982) Pharmacological properties of tracazolate: A new non-benzodiazepine anxiolytic agent. Eur. J. Pharmacol. 78, 323–333.
Patel, J. B. and Malick, J. B. (1983) Neuropharmacological Profile of an Anxiolytic, in Anxiolytics: Neurochemical, Behavioral and Clinical Perspectives ( Malick, J. B., Enna, S. J., and Yamamura, H. I., eds.) Raven, New York.
Patel, J. B. and Malick, J. B. (1984) Evaluation of the anxiolytic potential of selected 5-HT receptor antagonists in laboratory conflict procedures. Soc. Neurosci. Abst. 10, 1070.
Patel, J. B. and Migler, B. (1982) A sensitive and selective monkey conflict test. Pharmacol. Biochem. Behav. 17, 645–649.
Patel, J. B., Nelson, L. R., and Malick, J. B. (1980) Effects of selected psychoactive agents on bicuculline-induced convulsions in mice. Brain Res. Bull. 5 (suppl. 2), 639–642.
Patel, J. B.. Martin, C., and Malick, J. B. (1982) Differential antagonism of the anticonflict effects of typical and atvpical anxiolytics. Eur. J. Pharmacol. 86, 295–298.
Patel, J. B„ Stengel, J., Malick, J. B„ and Enna, S. J. (1984) Neurochemical characteristics of rats distinguished as benzodiazepine responders and non-responders in a new conflict test. Life Sci 34, 2647–2653.
Patel, J. B., Ross, L. E., and Malick, J. B. (1986) Detection of anxiolytics with partial agonist and mixed agonist/antagonist profiles in a battery of neuropharmacological tests. Pharmacologist 28, 112.
Peroutka, S.J. (1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol. Psychiatry 20, 971–979.
Poschel, B. P. H. (1971) A simple and specific screen for benzodiazepine- like drugs. Psychopharmacologia (Berl.) 19, 193–198.
Poschel, B. P. H., McCarthy, D. A., Chen, G., and Ensor, C. R. (1974) Pvrazopon (CI-683): A new antianxiety agent. Psychopharmacologia (Berl.) 35, 257–271.
Randall, L. O. and Schallek, W. (1967) Pharmacological Activity of Certain Benzodiazepines, in Psychopharmacology: A Review of Progress 1957-1967(Efron, D. H., ed.) US Public Health Service publication no. 1836, Bethesda, Maryland.
Riblet, L. A., Taylor, D. P., Eison, M. S., and Stanton, H. P. (1982) Pharmacology and neurochemistry of buspirone. J. Clin. Psychiatry 43, 11–16.
Sathananthan, G. L., Sanghvi, I., Phillips, N., and Gershon, S. (1975) MJ 9022: Correlation between neuroleptic potential and stereotypy. Curr. Ther. Res. 18, 701–705.
Schwob, J. and Johnson, A. (1975) Evidence for involvement of reninangiotensin system in isoproterenol dipsogenesis. Soc. Neurosci. Abst. 1, 467.
Sepinwall, J., Grodsky, F. S., and Cook, L. (1978) Conflict behaviors in the squirrel monkey: Effects of chlordiazepoxide, diazepam and N- desmethyldiazepam. J. Pharmacol. Exp. Ther. 204, 88–102.
Sprouse, J. S. and Aghajanian, G. K. (1985) Serotonergic dorsal raphe neurons: Electrophysiological responses in rats to5-HT1A and 5-1 HT1B receptor subtype ligands. Soc. Neurosci. Abst. 11, 47.
Stein, L. and Berger, B. (1971) Psychopharmacology of 7-chlor-5-(0- chlorophenyl)-l,3-dihydro-3-hydroxy-2H-l,4-benz. Odiazepine-2-one (lorazepam) in squirrel monkey and rat. Arztteimittelforsch. 21, 1073–1078.
Stern, W. C. (1979) Sleep and Anxiolytics, in Industrial Pharmacology vol. 3 Anxiolytics ( Fielding, S. and Lal, H., eds.) Futura, Mount Kisco, New York.
Stone, W. E. and Larid, M. J. (1978) Benzodiazepines and phenobarbital as antagonists of dissimilar chemical convulsants. Epilepsia 19, 361–368.
Sullivan, J. W., Keim, K. L., and Sepinwall, J. (1983) A preclinical evaluation of buspirone in neuropharmacology, EEG, and anticonflict test procedures. Soc. Neurosci. Abst. 9, 434.
Traber, J., Davies, M. A., Dompert, W. U., Glaser, T., Schuurman, T., and Seidel, P. R. (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res. Bull. 12, 741–744.
Turnbull, M. J., Watkins, J. W., and Wheeler, H. (1981) Demonstration of withdrawal hypcrexeitability following administration of benzodiazepines to rats and mice. Br. J. Pharmacol. 72, 495.
Vogel, J., Beer, B., and Clody, D. (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21, 1 - 7.
Wand, P., Kusinsky, K., and Sontag, K. H. (1973) Morphine-induced muscular rigidity in rats. Eur. J. Pharmacol. 24, 189–193.
Weidler, B. and Hempelmann, G. (1983) Intravenous Use of Benzodiazepines, in The Benzodiazepines: From Molecular Biology to Clinical Practice ( Costa, E., ed.) Raven, New York.
Willow, M. and Johnston, G. A. R. (1980) Enhancement of GABA binding by pentobarbitone. Neurosci. Lett. 18, 323–327.
Zbinden, G. and Randall, L. O. (1967) Pharmacology of benzodiazepines: Laboratory and clinical considerations. Adv. Pharmacol. 5, 213–291.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 The Humana Pres Inc.
About this chapter
Cite this chapter
Malick, J.B. (1987). Neuropsychopharmacological Drug Development. In: Williams, M., Malick, J.B. (eds) Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-4612-4828-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4828-6_5
Publisher Name: Humana Press
Print ISBN: 978-1-4612-9180-0
Online ISBN: 978-1-4612-4828-6
eBook Packages: Springer Book Archive